Departed
Lara Sullivan
Director
PYXS ·
Pyxis Oncology, Inc.
Also on the Effective Date, Dr. Sullivan resigned from the Board of Directors of the Company.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1351–1400 of 34667
Departed
Toby Neugebauer
director
FRMI ·
Fermi Inc.
As a result of his termination for Cause, Mr. Neugebauer was automatically removed from the Company’s board of directors.
Appointed
Nancy Saitta
Director
PLNH ·
Planet 13 Holdings Inc.
the Company’s Board of Directors (the “ Board ”) unanimously appointed Nancy Saitta and Leilani Bradford to serve as directors of the Company, to fill two newly created seats on the Board.
Appointed
Leilani Bradford
Director
PLNH ·
Planet 13 Holdings Inc.
the Company’s Board of Directors (the “ Board ”) unanimously appointed Nancy Saitta and Leilani Bradford to serve as directors of the Company, to fill two newly created seats on the Board.
Appointed
Arin Vahanian
Director
PLUN ·
Plutonian Acquisition Corp. II
Effective as of April 27, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Arin Vahanian, Hao Shen and Joel A. Gallo.
Appointed
Joel A. Gallo
Director
PLUN ·
Plutonian Acquisition Corp. II
Effective as of April 27, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Arin Vahanian, Hao Shen and Joel A. Gallo.
Appointed
Hao Shen
Director
PLUN ·
Plutonian Acquisition Corp. II
Effective as of April 27, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Arin Vahanian, Hao Shen and Joel A. Gallo.
Appointed
Jim S. Holotik
Director
USAC ·
USA Compression Partners, LP
appointed Jim S. Holotik to serve as a director on the board of directors of the General Partner
Appointed
Steven Nelson
Board Member
HCAT ·
Health Catalyst, Inc.
the board of directors (our Board) of Health Catalyst, Inc. (the Company), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Steven Nelson to the Board, effective May 1, 2026.
Departed
Daniel Hennessy
Director
INV ·
Innventure, Inc.
Daniel Hennessy resigned from the Board and the Company's other committees effective as of April 29, 2026.
Appointed
John Hewitt
Director
INV ·
Innventure, Inc.
On April 29, 2026, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed John Hewitt to fill the vacancy created by Mr. Hennessy's resignation, effective April 29, 2026.
Departed
Dirk A. Kempthorne
Director
FMC ·
FMC CORP
FMC Corporation (the “ Company ”) announced the passing of Dirk A. Kempthorne, a member of our board of directors (the “ Board ”) since 2009.
Departed
Suketu Upadhyay
Director
VRTX ·
VERTEX PHARMACEUTICALS INC / MA
Suketu Upadhyay informed the board of directors (the "Board") of Vertex Pharmaceuticals Incorporated (the "Company") of his decision not to stand for re-election as a director of the Company at the Company’s 2026 annual meeting of shareholders (the "2026 Annual Meeting").
Appointed
Grant T. Burcham
Class III director
HWBK ·
HAWTHORN BANCSHARES, INC.
the board of directors of each of the Company and Hawthorn Bank increased their respective sizes by one member, and appointed Grant T. Burcham to serve on both the Company's and Hawthorn Bank's board of directors to fill such newly created vacancies, in each case, effective April 29, 2026.
Appointed
Paul Adams
Director
IACQ ·
Irenic Acquisition Corp.
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
Appointed
Larry A. Lawson
Director
IACQ ·
Irenic Acquisition Corp.
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
Appointed
Kirk S. Hachigian
Director
IACQ ·
Irenic Acquisition Corp.
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
Departed
Robert L. Edwards, Jr.
Director
FWRD ·
FORWARD AIR CORP
On April 24, 2026, the board of directors (the “Board”) of Forward Air Corporation (the “Company”) received notice from Charles L. Anderson and Robert L. Edwards, Jr. that each will not be standing for re-election at the Company’s annual meeting of stockholders to be held on June 17, 2026 (the “2026 Annual Meeting”).
Departed
Charles L. Anderson
Director
FWRD ·
FORWARD AIR CORP
On April 24, 2026, the board of directors (the “Board”) of Forward Air Corporation (the “Company”) received notice from Charles L. Anderson and Robert L. Edwards, Jr. that each will not be standing for re-election at the Company’s annual meeting of stockholders to be held on June 17, 2026 (the “2026 Annual Meeting”).
Departed
William R. Jellison
Class I member of the Board of Directors
ANIK ·
Anika Therapeutics, Inc.
On April 24, 2026, both William R. Jellison, a Class I member of the Board of Directors (the "Board") of the Company, and Glenn R. Larsen, Ph.D., a Class II member of the Board, notified the Board of their resignation from the Board, including from all committees on which each serves effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
Departed
Glenn R. Larsen
Class II member of the Board
ANIK ·
Anika Therapeutics, Inc.
On April 24, 2026, both William R. Jellison, a Class I member of the Board of Directors (the "Board") of the Company, and Glenn R. Larsen, Ph.D., a Class II member of the Board, notified the Board of their resignation from the Board, including from all committees on which each serves effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
Appointed
Marc James
Class II Director
SLSN ·
SOLESENCE, INC.
Effective April 24, 2026, the Board of Directors of the Company (the "Board") appointed Marc James to serve as a Class II Director of the Board for the remainder of the term of Class II Directors of the Board, expiring at the 2026 Annual Meeting of Shareholders of the Company.
Appointed
Pedro J. Beltran
Member of the Board of Directors
BBOT ·
BridgeBio Oncology Therapeutics, Inc.
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Departed
Eli Wallace
Member of the Board of Directors
BBOT ·
BridgeBio Oncology Therapeutics, Inc.
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Appointed
Martin Babler
Class I Director
MPLT ·
MapLight Therapeutics, Inc.
The Board has nominated Martin Babler and Troy Cox as Class I director nominees to replace Dr. Malenka and Dr. Trenkle.
Departed
Jim Trenkle
Director
MPLT ·
MapLight Therapeutics, Inc.
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.
Appointed
Troy Cox
Class I Director
MPLT ·
MapLight Therapeutics, Inc.
The Board has nominated Martin Babler and Troy Cox as Class I director nominees to replace Dr. Malenka and Dr. Trenkle.
Departed
Robert Malenka
Director
MPLT ·
MapLight Therapeutics, Inc.
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.
Appointed
Prakash Raman
Class II director
OLMA ·
Olema Pharmaceuticals, Inc.
the Board appointed Dr. Prakash Raman to the Board as a Class II director, effective April 28, 2026
Appointed
William Sherman
Director
CXII ·
Churchill Capital Corp XII
On April 27, 2026, in connection with the IPO, William Sherman was appointed to the board of directors of the Company (the “ Board ”) effective April 28, 2026.
Appointed
David E. Lazar
Director
ATER ·
Aterian, Inc.
the Board increased the authorized number of directors to five and appointed Lazar to the Board to fill the vacancy created by such increase, effective immediately
Departed
Bharat Vasan
Director
STCB ·
Starco Brands, Inc.
Bharat Vasan notified the Board of Directors of Starco Brands, Inc. (the “Company”), that he resigns from the Board of Directors, effective April 27, 2026.
Departed
Neeraj Agrawal
Director
CXM ·
Sprinklr, Inc.
On April 23, 2026, Neeraj Agrawal notified the Board that he will not stand for re-election as a Class II director of the Company at the 2026 Annual Meeting.
Departed
Yvette Kanouff
Director
CXM ·
Sprinklr, Inc.
On April 23, 2026, Yvette Kanouff notified the board of directors (the “Board”) of Sprinklr, Inc. (the “Company”) that she will not stand for re-election as a Class II director of the Company at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).
Departed
Diane Bryant
Director
J ·
JACOBS SOLUTIONS INC.
On April 26, 2026, Diane Bryant resigned as a member of the Board of Directors of Jacobs Solutions Inc. (the “Company”).
Appointed
Mark Thornton
Director
XPEL ·
XPEL, Inc.
On April 23, 2026, the Board of Directors of XPEL, Inc. (the “Company) appointed Mark Thornton to the Board of Directors of the Company.
Departed
F. Brooks Bertsch
Director
FLXS ·
FLEXSTEEL INDUSTRIES INC
F. Brooks Bertsch resigned from the Board pursuant to the terms of the Stock Repurchase Agreement.
Departed
Steve Tyink
Director
EWSB ·
EWSB Bancorp, Inc. /MD/
On April 24, 2026, Steve Tyink resigned from his director and committee positions at EWSB Bancorp, Inc. (the “Company”) and East Wisconsin Savings Bank (the “Bank”) in order to focus on personal matters, effective on that date.
Appointed
Anand Eswaran
Director
FFIV ·
F5, INC.
On April 24, 2026, the Board of Directors (the “Board”) of F5, Inc. (the “Company”) appointed Mr. Anand Eswaran as a director.
Appointed
Stephen Haworth
Director
HTH ·
Hilltop Holdings Inc.
On April 23, 2026, the Board of Directors of Hilltop Holdings Inc., or the Company, appointed Dana Bober and Stephen Haworth as directors of the Company.
Appointed
Dana Bober
Director
HTH ·
Hilltop Holdings Inc.
On April 23, 2026, the Board of Directors of Hilltop Holdings Inc., or the Company, appointed Dana Bober and Stephen Haworth as directors of the Company.
Departed
Donna Grier
Director
KULR ·
KULR Technology Group, Inc.
voted to (i) remove Dr. Joanna Massey, Donna Grier, Aron Schwartz, and Shawn Canter from the board of directors of the Company effective immediately
Departed
Shawn Canter
Director
KULR ·
KULR Technology Group, Inc.
voted to (i) remove Dr. Joanna Massey, Donna Grier, Aron Schwartz, and Shawn Canter from the board of directors of the Company effective immediately
Appointed
Benjamin Andrew Frank
Director
KULR ·
KULR Technology Group, Inc.
elect Benjamin Andrew Frank and Dr. Michael Philip Kimel as members of the board of directors of the Company to serve until the next annual meeting of stockholders of the Company or until their successors have been duly elected and qualified, effective immediately
Departed
Dr. Joanna Massey
Director
KULR ·
KULR Technology Group, Inc.
voted to (i) remove Dr. Joanna Massey, Donna Grier, Aron Schwartz, and Shawn Canter from the board of directors of the Company effective immediately
Departed
Aron Schwartz
Director
KULR ·
KULR Technology Group, Inc.
voted to (i) remove Dr. Joanna Massey, Donna Grier, Aron Schwartz, and Shawn Canter from the board of directors of the Company effective immediately
Appointed
Dr. Michael Philip Kimel
Director
KULR ·
KULR Technology Group, Inc.
elect Benjamin Andrew Frank and Dr. Michael Philip Kimel as members of the board of directors of the Company to serve until the next annual meeting of stockholders of the Company or until their successors have been duly elected and qualified, effective immediately
Departed
Ali Behbahani
Director
ACLX ·
Arcellx, Inc.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Departed
David Lubner
Director
ACLX ·
Arcellx, Inc.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Departed
Kristin Myers
Director
ACLX ·
Arcellx, Inc.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.